COMMUNIQUÉS West-GlobeNewswire

Mise à disposition du Document d’Enregistrement Universel 2024, contenant le Rapport Financier Annuel
01/04/2025
Communiqué de presse Paris - Le 1 er avril 2025 - EUROAPI annonce la publication de son Document d’Enregistrement Universel 2024, au format ESEF, déposé auprès de l’Autorité des marchés financiers (AMF) le 1 er avril [...]
GRI Bio Announces Pricing of $5.0 Million Public Offering
01/04/2025
LA JOLLA, CA, April 01, 2025 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (“NKT”) cell modulators for the [...]
ProDentim Reviews (DOCTOR WARNING): Dentists & Buyers Reveal the Truth Behind This “Natural Smile Fix” Supplement
01/04/2025
2025 buyers reveal everything: From fresher breath and gum healing to the surprising downsides no one talks about. Ontario, April 01, 2025 (GLOBE NEWSWIRE) -- PRODENTIM In the fast-growing realm of oral health solutions [...]
Valneva’s Chikungunya Vaccine IXCHIQ® Now Authorized in EU for Adolescents Aged 12 and Above
01/04/2025
With this extension, IXCHIQ ® , the first vaccine against the chikungunya virus (CHIKV), is now available for administration for individuals 12 years of age and older in the European Union (EU). Saint Herblain (France [...]
Valneva : le vaccin contre le chikungunya, IXCHIQ®, désormais autorisé chez les adolescents dans l'UE
01/04/2025
Avec cet élargissement d’indication, IXCHIQ ® , le premier vaccin autorisé au monde contre le virus du chikungunya (CHIKV), est désormais disponible pour une administration dans l'Union Européenne (UE) chez les [...]
ProDentim Reviews (DOCTOR INVESTIGATES): The Probiotic Dental Hack Dentists Can’t Ignore in 2025
01/04/2025
Real users uncover what’s working—and what’s not—inside this trending oral probiotic now sweeping through the dental health market. ORLANDO, FL, April 01, 2025 (GLOBE NEWSWIRE) -- PRODENTIM In the fast-growing realm of [...]
REPEAT -- Radiance Announces FDA Clearance of IND Application for a Phase 1 Clinical Trial of RB-164™, an ROR-1 Targeted ADC, for Hematologic and Solid Malignancies
01/04/2025
BOSTON, Mass, April 01, 2025 (GLOBE NEWSWIRE) -- Radiance Biopharma, Inc. (“Radiance” or the “Company”), a clinical stage biopharmaceutical company advancing Antibody Drug Conjugates (‘ADCs’), today announced that the U [...]
Image Specialty Partners Announces Leadership Transition: Dr. Yan Kalika to Become Executive Chairman, Joel Idelson Appointed Chief Executive Officer
01/04/2025
SACRAMENTO, Calif., April 01, 2025 (GLOBE NEWSWIRE) -- Image Specialty Partners (“ISP”), a leading dental specialty support organization, today announced a strategic leadership transition to support its next phase of [...]
Cylinder Celebrates 100,000 Members Served, Advancing Access to Digestive Healthcare
01/04/2025
Digestive health platform builds on momentum with major partnerships, key leadership hires, and clinical research outcomes CHICAGO, April 01, 2025 (GLOBE NEWSWIRE) -- Cylinder , the leading virtual digestive health [...]
Grundy MD Consulting Physician Announces Expanded Focus on Services as a Missed Diagnosis Emergency Doctor & Malpractice Medical Legal Expert Witness for Head Injuries
01/04/2025
San Carlos, California , April 01, 2025 (GLOBE NEWSWIRE) -- Grundy MD Consulting Physician , led by board-certified emergency physician and medical-legal expert Dr. David Grundy, announced an expanded focus on services [...]
Thought Leadership & Innovation Foundation Awareness Month Published on American Hospital Association/Society for Health Care Strategy & Market Development Observance Calendar
01/04/2025
MCLEAN, Va., April 01, 2025 (GLOBE NEWSWIRE) -- Thought Leadership & Innovation Foundation (TLI) , a not-for-profit organization that works at the nexus of science, technology and public health, proudly announces [...]
A family doctor for every Canadian: The CFPC calls on federal parties to act
01/04/2025
MISSISSAUGA, Ontario, April 01, 2025 (GLOBE NEWSWIRE) -- The College of Family Physicians of Canada (CFPC) is calling on all federal political parties to commit to actions that protect and strengthen access to primary [...]
Un médecin de famille pour chaque Canadienne et Canadien : Le CMFC exhorte les partis fédéraux à agir
01/04/2025
MISSISSAUGA, Ontario, 01 avr. 2025 (GLOBE NEWSWIRE) -- Le Collège des médecins de famille du Canada (CMFC) exhorte les partis politiques fédéraux à prendre des mesures visant à protéger et renforcer l’accès aux soins [...]
Fifty 1 Labs, Inc. Celebrates Groundbreaking SpaceX, NASA, and ISS Yeast Experiment by Subsidiary Genetic Networks
01/04/2025
Groundbreaking Yeast Experiment from Dr. Nislow's lab on Last Night's SpaceX Fram2 Mission Advances Space-Based Biotechnology MELBOURNE, Fla., April 01, 2025 (GLOBE NEWSWIRE) -- via IBN -- Fifty 1 Labs, Inc. ( Ticker: [...]
Stride Autism Centers Named a Winner of the 2025 Top Workplaces USA Today During Autism Acceptance Month
01/04/2025
Stride Expands Across the Midwest, Celebrating its Tenth Center in Iowa and Sixth in Nebraska DES MOINES, Iowa, April 01, 2025 (GLOBE NEWSWIRE) -- Stride Autism Centers, a leading provider of center-based early [...]
Connect Biopharma Announces Positive Type C Meeting with the FDA for Rademikibart
01/04/2025
– FDA aligned on plan to initiate parallel Phase 2 trials of rademikibart in patients with moderate-to-severe asthma or COPD experiencing an acute exacerbation – – Expect to initiate both trials in Q2 2025 – SAN DIEGO, [...]
LogicMark Secures Approval to Deliver New Medical Alert with Cell Phone Tech to Veterans and Seniors Through U.S. General Services Administration
01/04/2025
The Freedom Alert Max brings life-saving fall detection, advanced geofencing capabilities, and patented 4G LTE mobile technology to vulnerable populations LOUISVILLE, Ky., April 01, 2025 (GLOBE NEWSWIRE) -- LogicMark, [...]
Capricor Therapeutics to Present at the 2025 Piper Sandler Virtual Cardio Day
01/04/2025
SAN DIEGO, April 01, 2025 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare diseases, today [...]
GRI Bio Reports Encouraging Interim 2-Week Safety Results from Ongoing Phase 2a Study of GRI-0621 in Idiopathic Pulmonary Fibrosis (“IPF”)
01/04/2025
The Independent Data Monitoring Committee (IDMC) has recommended to continue study as planned as there are no safety concerns seen in the data reviewed Interim results demonstrate GRI-0621 to be safe and well-tolerated [...]

Pages